PHARMA
Biocon Foundation Recognized By WHO-India
The CSR arm of Biocon has been awarded the Public Health Champion Award 2015 by the World Health Organization.
CBMG Raises US$19.6 Million With Private Placement Offering
The proceeds raised will be used to advance clinical trials of CBMG's lymphoma drugs and therapeutic platforms.
Eisai To Use Genomics’ Tools For Drug Discovery
The collaboration between Eisai and Genomics will focus on using genomic analyses to improve the drug development pipeline.
Green Cross Biologics To Enter Russian Market
A partnership with Russian pharmaceutical Nanolek sees Green Cross' biologics enter the rapidly growing Russian market.
WuXi’s Anti-Arthritis Antibody Accepted For CFDA Review
WuXi MedImmune Biopharmaceutical Co. Limited's anti-IL-6 monoclonal antibody is indicated for the treatment of rheumatoid arthritis.
MSD Joins A*STAR’s Manufacturing Consortium
Pharmaceutical giant MSD is the latest member of A*STAR's iPSP, a program to boost productivity in the high value chemistry sector.
Generic Hepatitis Drug Launched In India As Hepcvir
Generics manufacturer Cipla has been granted the license to produce Sofosbuvir in India under the brand name Hepcvir.
Innovent & Lilly Announce US$456 Million Cancer Drug Deal
Innovent and Lilly form a broad alliance to develop at least three cancer drugs over the next decade.
Lilly & Hanmi Ink US$690 Million Deal
Eli Lilly has acquired Hanmi's BTK inhibitor HM71224, a small molecule soon to enter Phase II trials for autoimmune diseases.
